The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(3S,4R)-3-Hydroxy-2,2-dimethyl-4-(2-phenyl-imidazol-1-yl)-chroman-6-carbonitrile ID: ALA517128
PubChem CID: 44564206
Max Phase: Preclinical
Molecular Formula: C21H19N3O2
Molecular Weight: 345.40
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC1(C)Oc2ccc(C#N)cc2[C@@H](n2ccnc2-c2ccccc2)[C@@H]1O
Standard InChI: InChI=1S/C21H19N3O2/c1-21(2)19(25)18(16-12-14(13-22)8-9-17(16)26-21)24-11-10-23-20(24)15-6-4-3-5-7-15/h3-12,18-19,25H,1-2H3/t18-,19+/m1/s1
Standard InChI Key: AHBKXQFEGKICII-MOPGFXCFSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
6.0549 -6.1189 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0538 -6.9466 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7689 -7.3596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7671 -5.7060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4828 -6.1152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4816 -6.9487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1987 -7.3640 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.9216 -6.9507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9228 -6.1173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2011 -5.6973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3284 -7.6611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6327 -6.5316 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6385 -5.7064 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.2011 -4.8720 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3407 -5.7069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6259 -5.2944 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.8672 -4.3890 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6122 -3.6040 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.7869 -3.6040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5319 -4.3889 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6911 -4.3849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1046 -5.0988 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9277 -5.0951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3371 -4.3790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9171 -3.6651 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0954 -3.6724 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
9 13 1 6
3 6 2 0
10 14 1 1
1 2 2 0
5 4 2 0
15 16 3 0
1 15 1 0
14 17 1 0
4 1 1 0
5 10 1 0
6 7 1 0
7 8 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 14 1 0
8 9 1 0
17 21 1 0
9 10 1 0
21 22 2 0
5 6 1 0
22 23 1 0
8 11 1 0
23 24 2 0
24 25 1 0
8 12 1 0
25 26 2 0
26 21 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 345.40Molecular Weight (Monoisotopic): 345.1477AlogP: 3.54#Rotatable Bonds: 2Polar Surface Area: 71.07Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.18CX Basic pKa: 5.76CX LogP: 3.48CX LogD: 3.47Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.77Np Likeness Score: -0.20
References 1. Zhang X, Qiu Y, Li X, Bhattacharjee S, Woods M, Kraft P, Lundeen SG, Sui Z.. (2009) Discovery and structure-activity relationships of a novel series of benzopyran-based K(ATP) openers for urge urinary incontinence., 17 (2): [PMID:19101153 ] [10.1016/j.bmc.2008.11.055 ]